Independence Day Special: 50% Off Premium Subscription 🕑 ... >> Independence Day Special: 50% Off >>
$0.272
-0.0059 (-2.12%)
At Close: Jul 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Cara Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 89.36. In total, the insiders bought 3 851 096 and sold 205 570 CARA shares in the last 100 trades.

Insider Power

(Last 100 transactions) 		89.36
Buy 3 851 096 Shares
Sell 205 570 Shares

Historical Insider Trades

Date Type Action Person Amount
Jun 04, 2024 Stock Option (Right to Buy) Buy Boudreau Helen M 195 000
Jun 04, 2024 Common Stock Buy Boudreau Helen M 150 647
Jun 04, 2024 Stock Option (Right to Buy) Buy Von Moltke Lisa 195 000
Jun 04, 2024 Common Stock Buy Von Moltke Lisa 150 647
Jun 04, 2024 Common Stock Buy Ives Jeffrey L. 150 647
Jun 04, 2024 Stock Option (Right to Buy) Buy Ives Jeffrey L. 195 000
Jun 04, 2024 Common Stock Buy Shiff Susan Ph.d. 150 647
Jun 04, 2024 Stock Option (Right to Buy) Buy Shiff Susan Ph.d. 195 000
Jun 04, 2024 Common Stock Buy Vogelbaum Martin 301 295
Jun 04, 2024 Stock Option (Right to Buy) Buy Vogelbaum Martin 390 000
May 02, 2024 Common Stock Sell Posner Christopher 3 936
Apr 05, 2024 Common Stock Sell Goncalves Joana 2 753
Apr 05, 2024 Common Stock Sell Terrillion Scott 2 753
Feb 29, 2024 Common Stock Sell Terrillion Scott 3 293
Feb 29, 2024 Common Stock Sell Posner Christopher 5 834
Feb 29, 2024 Common Stock Sell Goncalves Joana 3 293
Feb 08, 2024 Common Stock Sell Posner Christopher 35 575
Feb 01, 2024 Common Stock Buy Terrillion Scott 13 500
Feb 01, 2024 Common Stock Buy Maynard Ryan D 13 500
Feb 01, 2024 Common Stock Buy Goncalves Joana 13 500
Feb 01, 2024 Common Stock Buy Menzaghi Frederique Ph.d. 13 500
Feb 01, 2024 Common Stock Buy Posner Christopher 62 500
Feb 01, 2024 Common Stock Sell Posner Christopher 4 981
Nov 02, 2023 Common Stock Sell Posner Christopher 3 796
Aug 03, 2023 Common Stock Sell Posner Christopher 4 307
Click to get the best stock tips daily for free!

About Cara Therapeutics

Cara Therapeutics Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and immune cells. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of mod... CARA Profile

Golden Star

Ticker Date Change Price
PRU Jul 01 0.96% $117.53
PEG Jul 01 0.421% $73.63
ALSN Jul 01 1.21% $74.96
INTC Jul 01 1.26% $30.84
TXN Jul 01 2.23% $194.60
ODD Jul 01 3.98% $39.17
RDN Jun 28 0.257% $31.10
PDBC Jun 28 1.78% $14.05
SLM Jun 28 0.433% $20.79
VIGI Jun 28 1.00% $81.28
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT